Asiaprise Biotech

Asiaprise Biotech is a Malaysian investment holding company specializing in the life sciences and healthcare sectors. Operating as the healthcare arm of TH Group, the company utilizes a synergistic business model that integrates specialized medical treatment, pharmaceutical distribution, and contract research and manufacturing services. Its primary asset is the Nilai Medical Centre (formerly NCI Cancer Hospital), which serves as a regional center of excellence for oncology treatment and clinical research. Additionally, the group manages Asiaprise Pharma for the distribution of therapeutic and diagnostic products and holds strategic investments in contract outsourcing facilities such as Alpha Biologics for mammalian cell culture and Progenix Research for preclinical studies. This integrated approach allows Asiaprise Biotech to support the entire biotechnology supply chain from early-stage research to commercial patient care.